Quest Diagnostics IncorporatedDGXNYSE
Loading
Operating Expenses Over TimeStable
Percentile Rank86
3Y CAGR-1.4%
5Y CAGR+2.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-1.4%/yr
vs +7.5%/yr prior
5Y CAGR
+2.9%/yr
Recent deceleration
Acceleration
-9.0pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.92B | +1.2% |
| 2024 | $1.90B | +5.0% |
| 2023 | $1.81B | -9.9% |
| 2022 | $2.00B | +9.7% |
| 2021 | $1.83B | +10.0% |
| 2020 | $1.66B | +14.0% |
| 2019 | $1.46B | -2.8% |
| 2018 | $1.50B | -17.8% |
| 2017 | $1.82B | +4.9% |
| 2016 | $1.74B | - |